PO Olsson, A Hans, VS Henning - Diabetes Care, 1987 - Am Diabetes Assoc The miscibility of human semisynthetic regular and lente insulins (Actrapid
human/Monotard human) and human biosynthetic regular and NPH insulins (Humulin
regular/Humulin NPH) was studied in vitro and in 16 insulin-dependent ... Cited by 10 - Related articles - All 5 versions
MH Jawadi, LS Ho - The American journal of medicine, 1986 - ncbi.nlm.nih.gov Mixtures of short-acting and intermediate-acting insulins often represent an
effective regimen to achieve near-normal blood glucose values, yet controversy
exists concerning the stability and predictability of such mixtures. In a ... Cited by 6 - Related articles - All 2 versions
JD Best, CJ Ley, BJ Strauss, FP Alford, PM … - The Medical journal of Australia, 1987 - ncbi.nlm.nih.gov Premixing short- and intermediate-acting insulins in one syringe, with
refrigerated storage before injection, is practised by some centres in the
treatment of older patients with non-insulin-dependent diabetes. Because ... Cited by 2 - Related articles - All 2 versions
AL Peters, MB Davidson - Diabetes Care, 1987 - Am Diabetes Assoc Diabetes Care Skip to main page content. Home; Current Issue; Archive; Contact;
Subscribe; Alerts; Help. rss feed. Search GO. Advanced Search ». ... Cited by 4 - Related articles - All 4 versions
R Klauser, G Schernthaner, R Prager - Diabetes research and clinical practice, 1988 - ncbi.nlm.nih.gov 1: Diabetes Res Clin Pract. 1988 Sep 5;5(3):185-90. Mixtures of human intermediate
and human regular insulin in type 1 diabetic patients. ... Cited by 4 - Related articles - All 2 versions
K Hallas-Moller, M Jersild, K Petersen, J … - Danish medical bulletin, 1954 - ncbi.nlm.nih.gov 1: Dan Med Bull. 1954 Oct;1(5):132-42. The lente insulins, insulin-zinc suspensions.
HALLAS-MOLLER K, JERSILD M, PETERSEN K, SCHLICHTKRULL J. ... Cited by 4 - Related articles
G Forlani, G Santacroce, A Ciavarella, M … - Diabetes Care, 1986 - Am Diabetes Assoc The effects of mixing short- and intermediate-acting insulins (Actrapid MC and
Monotard MC) were studied in seven diabetic patients. On different days, 0.16
IU/kg of Actrapid and 0.24 IU/kg of Monotard were administered to each ... Cited by 6 - Related articles - All 4 versions
JS Corcoran, JS Yudkin - Diabetic Medicine, 1986 - interscience.wiley.com Blood glucose control in 12 C-peptide negative patients has been compared in a
crossover trial of four insulin treatment regimens: (1) porcine soluble and
isophane, (2) premixed porcine soluble/isophane, (3) porcine soluble and ... Cited by 6 - Related articles - All 3 versions
- ►nih.gov [PDF] I Murray, RB Wilson - British Medical Journal, 1953 - pubmedcentral.nih.gov There have been remarkably few hypoglycaemic reac- tions either in the
in-patients or in the out-patients. Such reactions as have occurred have been
quite typical and relatively mild, except in one or two instances in which ... Cited by 8 - Related articles - All 2 versions
M Rendell - Drug Development Research, 2008 - interscience.wiley.com The isolation of insulin by Banting and Best in 1922 was a historic event of
life-saving importance. Thousands of individuals doomed to die of type I
diabetes were saved. The inspiring story of insulin continued to grow and ... Related articles
